Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) EBT (2016 - 2025)

Historic EBT for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to -$182000.0.

  • Marimed's EBT rose 4567.16% to -$182000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year increase of 3846.23%. This contributed to the annual value of -$4.0 million for FY2024, which is 3984.23% up from last year.
  • As of Q3 2025, Marimed's EBT stood at -$182000.0, which was up 4567.16% from -$579000.0 recorded in Q2 2025.
  • Marimed's EBT's 5-year high stood at $11.4 million during Q2 2021, with a 5-year trough of -$9.6 million in Q4 2023.
  • For the 5-year period, Marimed's EBT averaged around $1.6 million, with its median value being $768000.0 (2021).
  • Its EBT has fluctuated over the past 5 years, first skyrocketed by 109909.57% in 2021, then crashed by 75050.25% in 2025.
  • Marimed's EBT (Quarter) stood at $768000.0 in 2021, then soared by 258.72% to $2.8 million in 2022, then plummeted by 449.55% to -$9.6 million in 2023, then soared by 68.71% to -$3.0 million in 2024, then skyrocketed by 93.96% to -$182000.0 in 2025.
  • Its last three reported values are -$182000.0 in Q3 2025, -$579000.0 for Q2 2025, and -$2.6 million during Q1 2025.